Lincoln International’s Global Healthcare Group Announces Record Year

Lincoln International remains one of the most active healthcare M&A advisors in 2021

Lincoln International’s global healthcare mergers and acquisitions (M&A) activity in 2021 eclipsed that of 2020 led by the firm’s growing sector capabilities and strong appetite for deals. In 2021, we completed transactions with or on behalf of some of the largest and most well-known names in healthcare private equity. Lincoln’s reputation for advising on, executing and closing high-quality assignments across healthcare services, life sciences, pharma outsourcing, medical products and healthcare information technology (IT) continues to strengthen. Lincoln is one of the only investment banks with dedicated, senior healthcare bankers covering markets across the Americas, Europe and Asia.


  • Lincoln International's global Healthcare Group celebrates record results in 2021.

Select Notable 2021 Healthcare Transactions

Related Perspectives

A New Standard for Beauty and Apparel: Inclusive Products and Sustainable Brands

Investor interest in environmental, social and governance (ESG) increases daily. As a result, companies and brands are now being called upon to prioritize ESG activities in an authentic and transparent… Read More

Reality Check: Assessing Private Equity’s 2022 Predictions

In Q4 2021, Lincoln International surveyed nearly 400 private equity investors on their expectations for dealmaking in the year ahead. In the three quarters since, public equity markets have seen… Read More

Lincoln Private Market Index Experiences First Decline Since Q1 2020

Public market volatility driven by heightened recession fears trickled to private market enterprise values in Q2 The Lincoln Private Market Index (Lincoln PMI), the only index that tracks changes in… Read More

Even as Possible Recession Looms, Prospects for Private Markets Look Strong

It is no secret that public markets are facing notable volatility. But from where I sit in the trenches of private market dealmaking, the near-term prospects for private equity remain… Read More

Meet Our Senior Team